Related Experiment Video
Updated: Jun 5, 2025

11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
12.6K
ASO Visual Abstract: Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2
Leah Winer1, Karen J Ruth2, Richard J Bleicher3
1Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Annals of Surgical Oncology
|December 3, 2024
Abstract
No abstract available in PubMed .

